131I lipiodol therapy for unresectable hepatocellular carcinoma

ANZ Journal of Surgery

Volumn 72, Issue 3, 2002, Pages 210-214

  Rindani, Rahoul B ^a   Hugh, Thomas J ^a   Roche, James ^b   Roach, Paul J ^b   Smith, Ross C ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

131I lipiodol; Chemoembolization; Hepatocellular carcinoma; Morbidity; Survival

Indexed keywords

ALPHA FETOPROTEIN; FLUOROURACIL; IODINATED POPPYSEED OIL; IODINE 131; CONTRAST MEDIUM; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MALE; PHASE 1 CLINICAL TRIAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TREATMENT OUTCOME; HOSPITALIZATION; LIVER TUMOR; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; QUALITY OF LIFE; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035984164     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2002.02348.x     Document Type: Article

References (32)

1. The development of hepatocellular cancer in humans
2. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma
3. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
4. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection
5. A comparison between primary and secondary liver cancer
6. Clinical significance of hepatic resection in hepatocellular carcinoma: Analysis by disease-free survival curves
7. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy
8. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer
9. Transection of the oesophagus for bleeding oesophageal varices
10. Biodistribution of rhenium-188 lipiodol infused via the hepatic artery of rats with hepatic tumours
11. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma
12. Small hepatocellular carcinoma: High dose internal radiation therapy with super-selective intra-arterial injection of I-113-labeled Lipiodol
13. Transarterial internal radiation therapy with I-131 Lipiodol for multifocal hepatocellular carcinoma: Immediate and long-term results
14. Internal radiation therapy for hepatocellular carcinoma: Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol
15. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: A preliminary report
16. Radiation therapy of hepatocellular carcinoma
17. Hepatic artery injection of I-131-labeled lipiodol: Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases
18. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma
19. Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image
20. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man
21. Nodular hepatocellular carcinoma: Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil
22. Intra-hepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
23. Postoperative recurrence of hepatocellular carcinoma
24. Prognostic factors after hepatectomy for hepatocellular carcinomas: A univariate and multivariate analysis
25. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma
26. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
27. Nonresectional therapies for hepatocellular carcinoma
28. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma
29. Treatment of solitary small hepatocellular carcinoma: Consideration of hepatic functional reserve and mode of recurrence
30. Hepatocellular carcinoma responding to chemotherapy with 5-FU
31. Hepatocellular carcinoma effectively treated by intravenous infusion of cisplatin
32. Non-surgical treatment of hepatocellular carcinoma